Curbing the Opioid Crisis: Optimal Dynamic Policies for Preventive and Mitigating Interventions

References

• Adalbert JR, Syal A, Varshney K, George B, Hom J, Ilyas AM (2023) The prescription drug monitoring program in a multifactorial approach to the opioid crisis: PDMP data, Pennsylvania, 2016–2020. BMC Health Services Res. 23(1):1–13.Crossref, Google Scholar
• Alagoz O, Chhatwal J, Burnside ES (2013) Optimal policies for reducing unnecessary follow-up mammography exams in breast cancer diagnosis. Decision Anal. 10(3):200–224.Link, Google Scholar
• Albert S, Brason FW, Sanford CK, Dasgupta N, Graham J, Lovette B (2011) Project Lazarus: Community-based overdose prevention in rural North Carolina. Pain Med. 12(2):S77–S85.Crossref, Google Scholar
• American Psychiatric Association (2013) Diagnostic and Statistical Manual of Mental Disorders, 5th ed. (American Psychiatric Association, Washington, DC).Crossref, Google Scholar
• Andereck JW, Reuter QR, Allen KC, Ansari S, Quarles AR, Cruz DS, VanZalen LA, Malik S, McCarthy DM, Kim HS (2019) A quality improvement initiative featuring peer-comparison prescribing feedback reduces emergency department opioid prescribing. Joint Commission J. Quality Patient Safety 45(10):669–679.Crossref, Google Scholar
• ASPA (2021) What is the U.S. opioid epidemic? Accessed April 15, 2024, https://www.hhs.gov/opioids/index.html.Google Scholar
• Baehren DF, Marco CA, Droz DE, Sinha S, Callan EM, Akpunonu P (2010) A statewide prescription monitoring program affects emergency department prescribing behaviors. Ann. Emergency Medicine 56(1):19–23.Crossref, Google Scholar
• Bao Y, Pan Y, Taylor A, Radakrishnan S, Luo F, Pincus HA, Schackman BR (2016) Prescription drug monitoring programs are associated with sustained reductions in opioid prescribing by physicians. Health Affairs 35(6):1045–1051.Crossref, Google Scholar
• Barbosa C, Dowd WN, Zarkin G (2020) Economic evaluation of interventions to address opioid misuse: A systematic review of methods used in simulation modeling studies. Value Health 23(8):1096–1108.Crossref, Google Scholar
• Brauer F, Castillo-Chavez C (2012) Mathematical Models in Population Biology and Epidemiology, 2nd ed. (Springer, New York).Crossref, Google Scholar
• Burke DS (2016) Forecasting the opioid epidemic. Science 354(6312):529.Crossref, Google Scholar
• Caulkins JP, Dietze P, Ritter A (2007) Dynamic compartmental model of trends in Australian drug use. Health Care Management Sci. 10(2):151–162.Crossref, Google Scholar
• CDC (2022) Information about opioid overdoses and deaths. Accessed April 15, 2024, https://www.cdc.gov/opioids/.Google Scholar
• Chang HY, Murimi IB, Jones CM, Alexander GC (2018) Relationship between high-risk patients receiving prescription opioids and high-volume opioid prescribers. Addiction 113(4):677–686.Crossref, Google Scholar
• Chen Q, Larochelle MR, Weaver DT, Lietz AP, Mueller PP, Mercaldo S, Wakeman SE, et al. (2019) Prevention of prescription opioid misuse and projected overdose deaths in the United States. JAMA Network Open 2(2):e187621–e187633.Crossref, Google Scholar
• Chhatwal J, Alagoz O, Burnside ES (2010) Optimal breast biopsy decision-making based on mammographic features and demographic factors. Oper. Res. 58(6):1577–1591.Link, Google Scholar
• Ciccarone D (2021) The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis. Current Opinion Psychiatry 34(4):344–350.Crossref, Google Scholar
• Coffin PO, Sullivan SD (2013) Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal. Ann. Internal Medicine 158(1):1–9.Crossref, Google Scholar
• Connery HS (2015) Medication-assisted treatment of opioid use disorder: Review of the evidence and future directions. Harvard Rev. Psychiatry 23(2):63–75.Crossref, Google Scholar
• Coşgun Ö, Büyüktahtakın İE (2018) Stochastic dynamic resource allocation for HIV prevention and treatment: An approximate dynamic programming approach. Comput. Indust. Engrg. 118:423–439.Crossref, Google Scholar
• Doleac JL, Mukherjee A (2018) The moral hazard of lifesaving innovations: Naloxone access, opioid abuse, and crime. Preprint, submitted May 2, http://dx.doi.org/10.2139/ssrn.3170278.Google Scholar
• Downey AB (2023) Modeling and Simulation in Python: An Introduction for Scientists and Engineers (No Starch Press, San Francisco).Google Scholar
• Enayati S, Özaltın OY (2020) Optimal influenza vaccine distribution with equity. Eur. J. Oper. Res. 283(2):714–725.Crossref, Google Scholar
• Fairley M, Humphreys K, Joyce VR, Bounthavong M, Trafton J, Combs A, Oliva EM, et al. (2021) Cost-effectiveness of treatments for opioid use disorder. JAMA Psychiatry 78(7):767–777.Crossref, Google Scholar
• Fan M, Tscheng D, Hamilton M, Hyland B, Reding R, Trbovich P (2019) Diversion of controlled drugs in hospitals: A scoping review of contributors and safeguards. J. Hospital Medicine 14(7):419–428.Crossref, Google Scholar
• Fass JA (2011) Prescription drug take-back programs. Amer. J. Health System Pharmacy 68(7):567–570.Crossref, Google Scholar
• Florence C, Luo F, Rice K (2021) The economic burden of opioid use disorder and fatal opioid overdose in the United States, 2017. Drug Alcohol Dependence 218:108350–108357.Crossref, Google Scholar
• Florence C, Luo F, Xu L, Zhou C (2016) The economic burden of prescription opioid overdose, abuse and dependence in the United States, 2013. Med. Care 54(10):901–906.Crossref, Google Scholar
• Franklin G, Sabel J, Jones CM, Mai J, Baumgartner C, Banta-Green CJ, Neven D, Tauben DJ (2015) A comprehensive approach to address the prescription opioid epidemic in Washington state: Milestones and lessons learned. Amer. J. Public Health 105(3):463–469.Crossref, Google Scholar
• Freedman DX, Senay EC (1973) Heroin epidemics. J. Amer. Medical Assoc. 223(10):1155–1156.Crossref, Google Scholar
• Gökçınar A, Çakanyıldırım M, Price T, Adams MC (2022) Balanced opioid prescribing via a clinical trade-off: Pain relief vs. adverse effects of discomfort, dependence, and tolerance/hypersensitivity. Decision Anal. 19(4):297–318.Link, Google Scholar
• Green J (2017) Epidemiology of opioid abuse and addiction. J. Emergency Nursing 43(2):106–113.Crossref, Google Scholar
• Haffajee RL, Jena AB, Weiner SG (2015) Mandatory use of prescription drug monitoring programs. J. Amer. Medical Assoc. 313(9):891–892.Crossref, Google Scholar
• Hawk KF, Vaca FE, D’Onofrio G (2015) Focus: Addiction: Reducing fatal opioid overdose: Prevention, treatment and harm reduction strategies. Yale J. Biology Medicine 88(3):235–245.Google Scholar
• HHS (2013) Addressing prescription drug abuse in the United States: Current activities and future opportunities. Accessed April 15, 2024, https://www.cdc.gov/drugoverdose/pdf/hhs_prescription_drug_abuse_report_09.2013.pdf.Google Scholar
• HHS (2017) HHS acting secretary declares public health emergency to address national opioid crisis. Accessed April 15, 2024, https://www.hhs.gov/about/news/2017/10/26/hhs-acting-secretary-declares-public-health-emergency-address-national-opioid-crisis.html.Google Scholar
• Hillier FS, Lieberman GJ (1995) Introduction to Operations Research (McGraw-Hill, New York).Google Scholar
• Homer J, Wakeland W (2021) A dynamic model of the opioid drug epidemic with implications for policy. Amer. J. Drug Alcohol Abuse 47(1):5–15.Crossref, Google Scholar
• Hyman SE (2005) Addiction: A disease of learning and memory. Amer. J. Psychiatry 162(8):1414–1422.Crossref, Google Scholar
• Irvine MA, Kuo M, Buxton JA, Balshaw R, Otterstatter M, Macdougall L, Milloy MJ, et al. (2019) Modelling the combined impact of interventions in averting deaths during a synthetic-opioid overdose epidemic. Addiction 114(9):1602–1613.Crossref, Google Scholar
• Jalali MS, Botticelli M, Hwang RC, Koh HK, McHugh RK (2020) The opioid crisis: Need for systems science research. Health Res. Policy Systems 18(1):88–93.Crossref, Google Scholar
• Joranson DE, Gilson AM (2005) Drug crime is a source of abused pain medications in the United States. J. Pain Symptom Management 30(4):299–301.Crossref, Google Scholar
• Kaplan EH, O’Keefe E (1993) Let the needles do the talking! Evaluating the New Haven needle exchange. Interfaces 23(1):7–26.Link, Google Scholar
• Kolodny A, Courtwright DT, Hwang CS, Kreiner P, Eadie JL, Clark TW, Alexander GC (2015) The prescription opioid and heroin crisis: A public health approach to an epidemic of addiction. Annual Rev. Public Health 36:559–574.Crossref, Google Scholar
• Lemonick MD, Park A (2007) The science of addiction. Time 170(3):42–48.Google Scholar
• Manchikanti L, Helm S 2nd, Fellows B, Janata JW, Pampati V, Grider JS, Boswell M (2012) Opioid epidemic in the United States. Pain Physician 15(3):ES9–ES38.Crossref, Google Scholar
• Manfredi P, D’Onofrio A (2013) Modeling the Interplay Between Human Behavior and the Spread of Infectious Diseases (Springer Science+Business Media, New York).Crossref, Google Scholar
• Maxwell S, Bigg D, Stanczykiewicz K, Carlberg-Racich S (2006) Prescribing naloxone to actively injecting heroin users: A program to reduce heroin overdose deaths. J. Addictive Diseases 25(3):89–96.Crossref, Google Scholar
• Molani S, Madadi M, Wilkes W (2019) A partially observable Markov chain framework to estimate overdiagnosis risk in breast cancer screening: Incorporating uncertainty in patients adherence behaviors. Omega 89:40–53.Crossref, Google Scholar
• Mueller SR, Walley AY, Calcaterra SL, Glanz JM, Binswanger IA (2015) A review of opioid overdose prevention and naloxone prescribing: Implications for translating community programming into clinical practice. Substance Abuse 36(2):240–253.Crossref, Google Scholar
• Naliboff BD, Wu SM, Schieffer B, Bolus R, Pham Q, Baria A, Aragaki D, Van Vort W, Davis F, Shekelle P (2011) A randomized trial of 2 prescription strategies for opioid treatment of chronic nonmalignant pain. J. Pain 12(2):288–296.Crossref, Google Scholar
• National Institute for Drug Abuse (2018) Fentanyl and other synthetic opioids drug overdose deaths. Accessed April 15, 2024, https://www.drugabuse.gov/.Google Scholar
• Patrick SW, Fry CE, Jones TF, Buntin MB (2016) Implementation of prescription drug monitoring programs associated with reductions in opioid-related death rates. Health Affairs 35(7):1324–1332.Crossref, Google Scholar
• Perrone J, Nelson LS (2012) Medication reconciliation for controlled substances—An “ideal” prescription-drug monitoring program. New England J. Medicine 366(25):2341–2343.Crossref, Google Scholar
• Pitt AL, Humphreys K, Brandeau ML (2018) Modeling health benefits and harms of public policy responses to the us opioid epidemic. Amer. J. Public Health 108(10):1394–1400.Crossref, Google Scholar
• Pope TM (2018) New laws limiting opioid prescriptions create undue barriers for patients with cancer and cancer survivors. The ASCO Post (September 25), https://ssrn.com/abstract=3265846.Google Scholar
• Rao IJ, Humphreys K, Brandeau ML (2021) Effectiveness of policies for addressing the US opioid epidemic: A model-based analysis from the Stanford-Lancet Commission on the North American Opioid Crisis. Lancet Regional Health Americas 3:100031–100041.Crossref, Google Scholar
• Rosenstrom E, Meshkinfam S, Simmons Ivy J, Hassani Goodarzi S, Capan M, Huddleston J, Romero-Brufau S (2022) Optimizing the first response to sepsis: An electronic health record-based Markov decision process model. Decision Anal. 19(4):265–296.Link, Google Scholar
• Rutkow L, Turner L, Lucas E, Hwang C, Alexander GC (2015) Most primary care physicians are aware of prescription drug monitoring programs, but many find the data difficult to access. Health Affairs 34(3):484–492.Crossref, Google Scholar
• Rydell CP, Caulkins JP, Everingham SS (1996) Enforcement or treatment? Modeling the relative efficacy of alternatives for controlling cocaine. Oper. Res. 44(5):687–695.Link, Google Scholar
• Samuelson PA (1983) Foundations of Economic Analysis (Harvard University Press, Cambridge, MA).Google Scholar
• Smyth BP, Barry J, Keenan E, Ducray K (2010) Lapse and relapse following inpatient treatment of opiate dependence. Irish Medical J. 103(6):176–179.Google Scholar
• Sondik EJ (1978) The optimal control of partially observable Markov processes over the infinite horizon: Discounted costs. Oper. Res. 26(2):282–304.Link, Google Scholar
• Stewart H, Malinowski A, Ochs L, Jaramillo J, McCall K III, Sullivan M (2015) Inside Maine’s medicine cabinet: Findings from the Drug Enforcement Administration’s medication take-back events. Amer. J. Public Health 105(1):e65–e71.Crossref, Google Scholar
• Stokowski L (2010) Adult cancer pain: Part 2—The latest guidelines for pain management. Accessed April 15, 2024, https://www.medscape.com/viewarticle/733067?form=fpf.Google Scholar
• Strang J, Babor T, Caulkins J, Fischer B, Foxcroft D, Humphreys K (2012) Drug policy and the public good: Evidence for effective interventions. Lancet 379(9810):71–83.Crossref, Google Scholar
• Straus MM, Ghitza UE, Tai B (2013) Preventing deaths from rising opioid overdose in the US–The promise of naloxone antidote in community-based naloxone take-home programs. Substance Abuse Rehabilitation 4:65–72.Crossref, Google Scholar
• Substance Abuse and Mental Health Services Administration (2021) Key substance use and mental health indicators in the United States: Results from the 2020 national survey on drug use and health (HHS publication no. pep21-07-01-003, NSDUH series h-56) (Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration, Rockville, MD).Google Scholar
• Tolles J, Luong T (2020) Modeling epidemics with compartmental models. J. Amer. Medical Assoc. 323(24):2515–2516.Crossref, Google Scholar
• Van Zee A (2009) The promotion and marketing of oxycontin: Commercial triumph, public health tragedy. Amer. J. Public Health 99(2):221–227.Crossref, Google Scholar
• Volkow ND, Frieden TR, Hyde PS, Cha SS (2014) Medication-assisted therapies—Tackling the opioid-overdose epidemic. New England J. Medicine 370(22):2063–2066.Crossref, Google Scholar
• Vowles KE, McEntee ML, Julnes PS, Frohe T, Ney JP, Van Der Goes DN (2015) Rates of opioid misuse, abuse, and addiction in chronic pain: A systematic review and data synthesis. Pain 156(4):569–576.Crossref, Google Scholar
• Weiner J, Bao Y, Meisel Z (2017) Prescription drug monitoring programs: Evolution and evidence. Accessed April 15, 2024, https://ldi.upenn.edu/our-work/research-updates/prescription-drug-monitoring-programs-evolution-and-evidence/.Google Scholar
• Yaesoubi R, Cohen T (2011a) Dynamic health policies for controlling the spread of emerging infections: Influenza as an example. PLoS One 6(9):e24043–e24054.Crossref, Google Scholar
• Yaesoubi R, Cohen T (2011b) Generalized Markov models of infectious disease spread: A novel framework for developing dynamic health policies. Eur. J. Oper. Res. 215(3):679–687.Google Scholar